about
Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cellsA Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.The Favorable Effect of Mesenchymal Stem Cell Treatment on the Antioxidant Protective Mechanism in the Corneal Epithelium and Renewal of Corneal Optical Properties Changed after Alkali BurnsTargeted neural differentiation of murine mesenchymal stem cells by a protocol simulating the inflammatory site of neural injury.Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations.The Identification of Interferon-γ as a Key Supportive Factor for Retinal Differentiation of Murine Mesenchymal Stem Cells.Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.The Supportive Role of Insulin-Like Growth Factor-I in the Differentiation of Murine Mesenchymal Stem Cells into Corneal-Like Cells.Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface.The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cellsA local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotypeDistinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cellsImmunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors
P50
Q34291269-1942DEB4-4DEC-4CA4-834E-EAC1842C0147Q35975412-241B493A-67B8-4D1C-A9C7-3B7B6B88DE89Q36530413-ABC586F2-452E-4F1A-9232-713BBF65DB8DQ48105363-639B0A17-BB4E-4A35-8600-33215EBAA139Q48336724-C42EE7B4-9C06-4DE8-A01F-D5FCED8D60D1Q50733062-43D757B0-B7CA-478A-BCF2-831D709FE80EQ50879668-4EA29590-CCD6-4AC7-8549-8987C11E9CDAQ51703801-E1BA4CE7-430D-46AF-BE71-24D117190802Q53128762-89CB2017-C844-433B-B8CE-117E1720E159Q54718619-A4997FA5-8B61-4FE4-BE07-8F1388EE2735Q63437244-93079932-0943-4581-BAD7-C2F793571578Q63437246-367CAC08-F0FB-4559-A2DA-EA63C86EE284Q63437254-F66BDBA0-F9C2-48EE-850D-8FCEDB7E8E7DQ91643078-7068109E-647E-4289-A94F-2C0059EAA2E3
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eliska Javorkova
@en
Eliska Javorkova
@nl
type
label
Eliska Javorkova
@en
Eliska Javorkova
@nl
prefLabel
Eliska Javorkova
@en
Eliska Javorkova
@nl
P31
P496
0000-0001-9813-6026